Inhibition_NN
of_IN
IL-4-inducible_JJ
gene_NN
expression_NN
in_IN
human_JJ
monocytes_NNS
by_IN
type_NN
I_CD
and_CC
type_NN
II_CD
interferons_NNS
._.

The_DT
Th2-type_JJ
cytokines_NNS
,_,
interleukin-4_NN
-LRB-_-LRB-
IL-4_NN
-RRB-_-RRB-
and_CC
interleukin-13_NN
-LRB-_-LRB-
IL-13_NN
-RRB-_-RRB-
,_,
induce_VBP
expression_NN
of_IN
a_DT
distinct_JJ
subset_NN
of_IN
genes_NNS
in_IN
human_JJ
monocytes_NNS
,_,
including_VBG
FcepsilonRIIb_NN
-LRB-_-LRB-
CD23_NN
-RRB-_-RRB-
,_,
15-lipoxygenase_NN
,_,
IL-1_NN
receptor_NN
antagonist_NN
-LRB-_-LRB-
IL-1ra_NN
-RRB-_-RRB-
,_,
and_CC
type_NN
I_CD
and_CC
type_NN
II_CD
IL-1_NN
receptors_NNS
-LRB-_-LRB-
IL-1R_NN
-RRB-_-RRB-
._.

Type_NN
I_NN
interferons_NNS
-LRB-_-LRB-
IFN-alpha_NN
and_CC
IFN-beta_NN
-RRB-_-RRB-
and_CC
type_NN
II_CD
interferon_NN
-LRB-_-LRB-
IFN-gamma_NN
-RRB-_-RRB-
inhibit_VBP
induction_NN
of_IN
these_DT
genes_NNS
by_IN
IL-4_NN
and_CC
IL-13_NN
._.

However_RB
,_,
the_DT
mechanism_NN
by_IN
which_WDT
IFNs_NNS
mediate_VBP
this_DT
inhibition_NN
has_VBZ
not_RB
been_VBN
defined_VBN
._.

In_IN
this_DT
overview_NN
,_,
we_PRP
discuss_VBP
the_DT
role_NN
of_IN
the_DT
transcription_NN
factor_NN
,_,
STAT6_NN
-LRB-_-LRB-
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription-6_NN
-RRB-_-RRB-
in_IN
mediating_VBG
IL-4_NN
-_:
and_CC
IL-13-induced_JJ
gene_NN
expression_NN
in_IN
monocytes_NNS
._.

We_PRP
also_RB
discuss_VBP
our_PRP$
recent_JJ
findings_NNS
that_IN
type_NN
I_CD
and_CC
type_NN
II_CD
IFNs_NNS
suppress_VBP
IL-4_NN
\/_:
IL-13-inducible_JJ
gene_NN
expression_NN
by_IN
inhibiting_VBG
tyrosine_NN
phosphorylation_NN
and_CC
nuclear_JJ
translocation_NN
of_IN
STAT6_NN
._.

The_DT
ability_NN
of_IN
type_NN
I_CD
and_CC
type_NN
II_CD
IFNs_NNS
to_TO
inhibit_VB
IL-4_NN
\/_:
IL-13-induced_JJ
STAT6_NN
activity_NN
is_VBZ
dose_NN
-_JJ
and_CC
time-dependent_JJ
,_,
and_CC
is_VBZ
not_RB
unique_JJ
to_TO
monocytes_NNS
because_IN
IFNs_NNS
induce_VBP
the_DT
same_JJ
effects_NNS
in_IN
fibroblasts_NNS
._.

Inhibition_NN
of_IN
STAT6_NN
activity_NN
is_VBZ
not_RB
evident_JJ
unless_IN
cells_NNS
are_VBP
preincubated_VBN
with_IN
IFN_NN
for_IN
at_IN
least_JJS
1_CD
h_NN
before_IN
IL-4_NN
stimulation_NN
._.

Furthermore_RB
,_,
inhibition_NN
can_MD
be_VB
blocked_VBN
by_IN
actinomycin_NN
D_NN
,_,
indicating_VBG
a_DT
requirement_NN
for_IN
de_FW
novo_FW
transcription_NN
._.

We_PRP
propose_VBP
a_DT
model_NN
in_IN
which_WDT
stimulation_NN
of_IN
monocytes_NNS
by_IN
IFN_NN
activates_VBZ
de_FW
novo_FW
synthesis_NN
of_IN
an_DT
inhibitory_JJ
factor_NN
,_,
possibly_RB
one_CD
or_CC
more_JJR
members_NNS
of_IN
the_DT
SOCS\/SSI\/CIS_NN
gene_NN
family_NN
,_,
capable_JJ
of_IN
suppressing_VBG
activation_NN
of_IN
STAT6_NN
by_IN
IL-4_NN
and_CC
IL-13_NN
._.

Because_IN
STAT6_NN
activation_NN
plays_VBZ
an_DT
essential_JJ
role_NN
in_IN
IL-4_NN
\/_:
IL-13-induced_JJ
gene_NN
expression_NN
,_,
the_DT
ability_NN
of_IN
IFN-beta_NN
and_CC
IFN-gamma_NN
to_TO
inhibit_VB
STAT6_NN
activity_NN
provides_VBZ
an_DT
explanation_NN
for_IN
how_WRB
IFNs_NNS
can_MD
suppress_VB
IL-4_NN
\/_:
IL-13-inducible_JJ
gene_NN
expression_NN
._.

